| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Chief Commercial Officer | Common Stock | 127,107 | $3,213,265 | $25.28 | 02 Jul 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 02 Jul 2024 | 1 | -$237,480 | 4 | Chief Commercial Officer | 03 Jul 2024, 17:27 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 04 Jan 2024 | 2 | -$2,508 | 4 | Chief Commercial Officer | 08 Jan 2024, 17:17 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 03 Jul 2023 | 1 | -$315,142 | 4 | Chief Commercial Officer | 06 Jul 2023, 18:04 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 04 Jan 2023 | 1 | $0 | 4 | Chief Commercial Officer | 05 Jan 2023, 18:21 |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 20 Jun 2022 | 0 | $0 | 3 | Chief Commercial Officer | 29 Jun 2022, 19:11 |